Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
59581-9 Coxsackievirus A7 Ab.IgM Titr Ser Pt SemiQn IF   ACTIVE Coxsackievirus A7 IgM Ab [Titer] in Serum by Immunofluorescence   MAJ DefinitionDescription     titer Negative Titer results (i.e. 1:2, 1:4, etc.)           MICRO   59581-9   IF     Both       0 CV A7 IgM Titr Ser IF       N   ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A7; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr 2.75 2.32               {titer}       0
59582-7 Coxsackievirus A24 Ab.IgG Titr Ser Pt SemiQn IF   ACTIVE Coxsackievirus A24 IgG Ab [Titer] in Serum by Immunofluorescence   MAJ DefinitionDescription     titer Negative Titer results (i.e. 1:2, 1:4, etc.)           MICRO   59582-7   IF     Both       0 CV A24 IgG Titr Ser IF       N   ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A24; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr 2.75 2.32               {titer}       0
59583-5 Coxsackievirus A16 Ab.IgG Titr Ser Pt SemiQn IF   ACTIVE Coxsackievirus A16 IgG Ab [Titer] in Serum by Immunofluorescence   MAJ DefinitionDescription     titer Negative Titer results (i.e. 1:2, 1:4, etc.)           MICRO   59583-5   IF     Both       0 CV A16 IgG Titr Ser IF       N   ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A16; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr 2.75 2.32               {titer}       0
59584-3 Coxsackievirus A7 Ab.IgG Titr Ser Pt SemiQn IF   ACTIVE Coxsackievirus A7 IgG Ab [Titer] in Serum by Immunofluorescence   MAJ DefinitionDescription     titer Negative Titer results (i.e. 1:2, 1:4, etc.)           MICRO   59584-3   IF     Both       0 CV A7 IgG Titr Ser IF       N   ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A7; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr 2.75 2.32               {titer}       0
59585-0 GSTP1 gene+APC gene methylation Arb Tiss Pt Ord Molgen   ACTIVE GSTP1 gene+APC gene methylation [Presence] in Tissue by Molecular genetics method   MIN DefinitionDescription       Positive Negative           MOLPATH   59585-0   Molgen     Both       0 GSTP1+APC gene methylation Tiss Ql       N   Adenomatosis polyposis coli; adenomatous polyposis coli; Adenomatous polyposis of the colon; Arbitrary; BTPS2; DNA methylation; DP2; DP2.5; DP3; Familial adenomatous polyposis; FAP; FPC; GS; GSTP1+APC gene methylation; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; PCR; Point in time; PPP1R46; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified 2.73 2.32                       0
59586-8 HLA Ab.IgG PrThr Ser Pt Ord IF   ACTIVE HLA IgG Ab [Presence] in Serum by Immunofluorescence   MIN DefinitionDescription       Positive or Negative           HLA   59586-8   IF     Both       0 HLA IgG Ser Ql IF       N   ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cytotoxic-lymphocytic antibody; FA; Fluorescent antibody; Fluoresent; HLA ANTIGEN; Human Leukocyte Antigen; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Lymphocyte antibody; Lymphocytotoxic antibody; Ordinal; Panel Reactive AB; Panel Reactive antibody; Point in time; PR; PRA; QL; Qual; Qualitative; Random; Screen; Serum; SR; Time Resolved Fluorescence; TRF 2.56 2.36                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
59587-6 Homovanillate MCnc Urine XXX Qn     ACTIVE Homovanillate [Mass/volume] in Urine collected for unspecified duration   MIN DefinitionDescription     mg/L             CHEM   59587-6         Both       0 HVA ?Tm Ur-mCnc       N   ?Tm; 3-methoxy-4-hydroxy-phenylacetic acid; Chemistry; Homovanilic; Homovanillic acid; HVA; Level; Mass concentration; QNT; Quan; Quant; Quantitative; Tumor marker; UA; UR; Urn 2.73 2.32               mg/L       0
59588-4 1-Hydroxymidazolam MCnt Meconium Pt Qn     ACTIVE 1-Hydroxymidazolam [Mass/mass] in Meconium   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59588-4         Both       0 1OH-midazolam Mec-mCnt       N   1-Hydroxy midazolam; 1OH-midazolam; Alpha hydroxymidazolam; Alpha-hydroxymidazolam; Chlonazepam metabolite; DRUG/TOXICOLOGY; Drugs; i; Mass content; Mec; Point in time; QNT; Quan; Quant; Quantitative; Random 2.7 2.32               ng/g       0
59589-2 1-Hydroxymidazolam MCnc Urine Pt Qn     ACTIVE 1-Hydroxymidazolam [Mass/volume] in Urine   MIN DefinitionDescription     ng/mL 5ng/mL           DRUG/TOX   59589-2         Both       0 1OH-midazolam Ur-mCnc       N   1-Hydroxy midazolam; 1OH-midazolam; Alpha hydroxymidazolam; Alpha-hydroxymidazolam; Chlonazepam metabolite; DRUG/TOXICOLOGY; Drugs; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 2.32               ng/mL       0
5959-2 Coagulation tissue factor induced.factor substitution^immediately after addition of normal plasma Time PPP Pt Qn Coag   ACTIVE Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma   MIN DefinitionDescription     s             COAG   5959-2   Coag     Observation       0 PT imm NP PPP       Y   Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; imm NP; Immediatedly after 1:1 addition of; Mixing studies; Plas; Platelet poor plasma; Point in time; Pro time; Prothrombin time; Protime; PT; PT correction study; PT immediate mix; PT incubated mix; QNT; Quan; Quant; Quantitative; Random; Tilt tube 2.73 1.0d               s       0
59590-0 1-Hydroxymidazolam MCnc Urine Pt Qn Confirm   ACTIVE 1-Hydroxymidazolam [Mass/volume] in Urine by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59590-0   Confirm     Both       0 1OH-midazolam Ur Cfm-mCnc       N   1-Hydroxy midazolam; 1OH-midazolam; Alpha hydroxymidazolam; Alpha-hydroxymidazolam; Cfm; Chlonazepam metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; i; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 2.32               ng/mL       0
59591-8 7-Aminoclonazepam MCnc Bld Pt Qn     ACTIVE 7-Aminoclonazepam [Mass/volume] in Blood   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59591-8         Both       0 7Aminoclonazepam Bld-mCnc       N   7-amino clonazepam; 7Aminoclonazepam; Addiction; Blood; Clonazepam metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.7 2.32               ng/mL       0
59592-6 7-Aminoclonazepam MCnc Bld Pt Qn Confirm   ACTIVE 7-Aminoclonazepam [Mass/volume] in Blood by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59592-6   Confirm     Both       0 7Aminoclonazepam Bld Cfm-mCnc       N   7-amino clonazepam; 7Aminoclonazepam; Addiction; Blood; Cfm; Clonazepam metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.73 2.32               ng/mL       0
59593-4 7-Aminoclonazepam MCnc Body fld Pt Qn     ACTIVE 7-Aminoclonazepam [Mass/volume] in Body fluid   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59593-4         Both       0 7Aminoclonazepam Fld-mCnc       N   7-amino clonazepam; 7Aminoclonazepam; Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Clonazepam metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random 2.7 2.32               ng/mL       0
59594-2 7-Aminoclonazepam MCnc Body fld Pt Qn Confirm   ACTIVE 7-Aminoclonazepam [Mass/volume] in Body fluid by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59594-2   Confirm     Both       0 7Aminoclonazepam Fld Cfm-mCnc       N   7-amino clonazepam; 7Aminoclonazepam; Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; Clonazepam metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random 2.7 2.32               ng/mL       0
59595-9 7-Aminoclonazepam MCnc Ser/Plas Pt Qn Confirm   ACTIVE 7-Aminoclonazepam [Mass/volume] in Serum or Plasma by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59595-9   Confirm     Both       0 7Aminoclonazepam SerPl Cfm-mCnc       N   7-amino clonazepam; 7Aminoclonazepam; Addiction; Cfm; Clonazepam metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 2.32               ng/mL       0
59596-7 7-Aminoclonazepam MCnt Tiss Pt Qn     ACTIVE 7-Aminoclonazepam [Mass/mass] in Tissue   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59596-7         Both       0 7Aminoclonazepam Tiss-mCnt       N   7-amino clonazepam; 7Aminoclonazepam; Addiction; Clonazepam metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Mass Content; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified 2.7 2.32               ng/g       0
59597-5 7-Aminoclonazepam MCnt Tiss Pt Qn Confirm   ACTIVE 7-Aminoclonazepam [Mass/mass] in Tissue by Confirmatory method   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59597-5   Confirm     Both       0 7Aminoclonazepam Tiss Cfm-mCnt       N   7-amino clonazepam; 7Aminoclonazepam; Addiction; Cfm; Clonazepam metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Mass content; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified 2.7 2.32               ng/g       0
59598-3 acetaZOLAMIDE MCnc Bld Pt Qn     ACTIVE Acetazolamide [Mass/volume] in Blood   MIN DefinitionDescription     ug/mL 0.5 ug/mL           DRUG/TOX   59598-3         Both       0 acetaZOLAMIDE Bld-mCnc       N   Acetadiazol; Acetazolam; AK-Zol; Blood; Diamox; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.7 2.32               ug/mL       0
59599-1 Alpha hydroxyalprazolam MCnc Bld Pt Qn     ACTIVE Alpha hydroxyalprazolam [Mass/volume] in Blood   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59599-1         Both       0 A-OH Alpraz Bld-mCnc       N   Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; Blood; DRUG/TOXICOLOGY; Drugs; Hydroxy alprazolam; Hydroxyalpraz; Level; Mass concentration; OH-Alpraz; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.7 2.32               ng/mL       0
596-7 Bacteria Prid Amnio fld Pt Nom Culture   ACTIVE Bacteria identified in Amniotic fluid by Culture   NAM DefinitionDescription                   MICRO   596-7   Culture     Both       0 Bacteria Amn Cult           AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Bact; C&S; Cult; Cultures; Gyn; Gynecology; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; OB; ObGyn; Obstetrics; Point in time; Random 2.78 1                     Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; 0
5960-0 Coagulation tissue factor induced.factor substitution^20M post incubation.37 deg c after addition of normal plasma Time PPP^Control Pt Qn Tilt tube   DEPRECATED Deprecated Prothrombin time (PT) factor substitution in Platelet poor plasma from control by Coagulation assay --20M post incubation with normal plasma   DEL DefinitionDescription                   COAG   5960-0   Tilt tube             0 Deprecated PT PPP Cont Qn           @37c; 20M p Inc; After; Coag; Contrl; Control; degree; Fac; Fact; Hematology; Heme; Mixing studies; Normal; Plas; Platelet poor plasma; Point in time; Pro time; Prothrombin time; Protime; PST; PT; PT correction study; PT immediate mix; PT incubated mix; QNT; Quan; Quant; Quantitative; Random 2.36 1.0d       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
59600-7 Alpha hydroxyalprazolam MCnc Bld Pt Qn Confirm   ACTIVE Alpha hydroxyalprazolam [Mass/volume] in Blood by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59600-7   Confirm     Both       0 A-OH Alpraz Bld Cfm-mCnc       N   Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Hydroxy alprazolam; Hydroxyalpraz; LC/MS/MS; Level; Mass concentration; OH-Alpraz; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.7 2.32               ng/mL       0
59601-5 Alpha hydroxyalprazolam MCnc Body fld Pt Qn     ACTIVE Alpha hydroxyalprazolam [Mass/volume] in Body fluid   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59601-5         Both       0 A-OH Alpraz Fld-mCnc       N   Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Hydroxy alprazolam; Hydroxyalpraz; Level; Mass concentration; OH-Alpraz; Point in time; QNT; Quan; Quant; Quantitative; Random 2.7 2.32               ng/mL       0
59602-3 Alpha hydroxyalprazolam MCnc Body fld Pt Qn Confirm   ACTIVE Alpha hydroxyalprazolam [Mass/volume] in Body fluid by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59602-3   Confirm     Both       0 A-OH Alpraz Fld Cfm-mCnc       N   Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; GCMS; Hydroxy alprazolam; Hydroxyalpraz; LC/MS/MS; Level; Mass concentration; OH-Alpraz; Point in time; QNT; Quan; Quant; Quantitative; Random 2.7 2.32               ng/mL       0
104,672 results found